Revolutionizing Real-World Evidence practices in Europe
Revolutionizing Real-World Evidence practices in Europe
GREG’s aim
The GREG project creates, tests, and shares practical, evidence-based guidance and tools to help generate and use Real-World Evidence (RWE). By improving how RWE informs the development and evaluation of medicines, medical devices, and drug-device combinations, GREG supports better decision-making for regulators and Health Technology Assessment (HTA) bodies.

GREG’s impact
- Better informed decision-making using Real-World Data (RWD) and Real-World Evidence (RWE) contributing to a better allocation of resources towards safe and effective innovations.
- Faster market entry for safe and effective medicinal products, devices, and combinations.
- Improved access to healthcare technologies and innovations to meet the needs of patients and of the diverse European healthcare systems.
